Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:970074rdf:typepubmed:Citationlld:pubmed
pubmed-article:970074lifeskim:mentionsumls-concept:C1882657lld:lifeskim
pubmed-article:970074lifeskim:mentionsumls-concept:C0002253lld:lifeskim
pubmed-article:970074lifeskim:mentionsumls-concept:C0017889lld:lifeskim
pubmed-article:970074lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:970074lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:970074pubmed:issue2lld:pubmed
pubmed-article:970074pubmed:dateCreated1976-11-21lld:pubmed
pubmed-article:970074pubmed:abstractTextThe concentration of GPC in the 4 segments (initial segment, caput, corpus and cauda) of the rat epididymis was examined at various times (4 hours. 2, 5, 10 and 20 days) following injection of a lesion-forming dose (90 mg/kg body weight) of alpha-chlorohydrin and bilateral ligation of the vasa efferentia. There was a reduction in the overall GPC concentration of the epididymis 2 days after both treatments and a further decrease until 20 days when a slight increase occurred. It is suggested that a lesion-forming dose of alpha-chlorohydrin, like ligation of the vasa efferentia, could inhibit the synthesis and/or release of GPC within the epididymis by blocking off androgen supply in the testicular fluid.lld:pubmed
pubmed-article:970074pubmed:languageenglld:pubmed
pubmed-article:970074pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:970074pubmed:citationSubsetIMlld:pubmed
pubmed-article:970074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:970074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:970074pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:970074pubmed:statusMEDLINElld:pubmed
pubmed-article:970074pubmed:monthJunlld:pubmed
pubmed-article:970074pubmed:issn0587-2421lld:pubmed
pubmed-article:970074pubmed:authorpubmed-author:WhiteI GIGlld:pubmed
pubmed-article:970074pubmed:authorpubmed-author:Brown-Woodman...lld:pubmed
pubmed-article:970074pubmed:authorpubmed-author:SaleDDlld:pubmed
pubmed-article:970074pubmed:issnTypePrintlld:pubmed
pubmed-article:970074pubmed:volume7lld:pubmed
pubmed-article:970074pubmed:ownerNLMlld:pubmed
pubmed-article:970074pubmed:authorsCompleteYlld:pubmed
pubmed-article:970074pubmed:pagination155-62lld:pubmed
pubmed-article:970074pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-E...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-T...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-A...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-T...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-R...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-G...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-M...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-T...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-L...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-C...lld:pubmed
pubmed-article:970074pubmed:meshHeadingpubmed-meshheading:970074-S...lld:pubmed
pubmed-article:970074pubmed:year1976lld:pubmed
pubmed-article:970074pubmed:articleTitleThe glycerylphosphorylcholine content of the rat epididymis after injecting alpha-chlorohydrin and ligating the vasa efferentia.lld:pubmed
pubmed-article:970074pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:970074lld:pubmed